Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px

Document › Details

MorphoSys AG. (10/13/20). "Press Release: MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds [Not for US, AU, ZA, JP, et al.]". Planegg.

	Organisation	MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
	Group	MorphoSys (Group)
	Organisation 2	Goldman Sachs International
	Group	Goldman Sachs (Group)
	Product	BIOTECH
	Product 2	investment banking
	Person	Kress, Jean-Paul (MorphoSys 201909– CEO before Syntimmune + Biogen + Sanofi Genzyme)
	Person 2	Pomrehn, Anja (MorphoSys 202010 SVP)

Original document
accessed by [iito] on 2020-10-14

Record changed: 2020-10-26

Picture [iito] Made Without Love 650x80px

More documents for MorphoSys (Group)

[1] MorphoSys AG. (7/15/21). "Press Release: MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology". Planegg....
[2] MorphoSys AG. (7/15/21). "Press Release: MorphoSys Concludes a US$ 100 Million Capital Increase to Implement the Purchase of 1,337,552 Shares by Royalty Pharma". Planegg....
[3] MorphoSys AG. (6/2/21). "Press Release (Ad hoc): MorphoSys to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma". Planegg & Cambridge, MA....
[4] MorphoSys AG. (6/2/21). "Press Release: MorphoSys to Acquire Constellation Pharmaceuticals". Planegg & Cambridge, MA....
[5] BioNTech SE. (5/18/21). "Press Release: BioNTech Broadens Management Board by Appointing Jens Holstein as CFO". Mainz....
[6] MorphoSys AG. (1/6/21). "Press Release: MorphoSys Appoints Sung Lee as Chief Financial Officer". Planegg....
[7] MorphoSys AG. (12/2/20). "Press Release: MorphoSys' Licensee Announces Approval by the European Commission for Tremfya (guselkumab) for Treatment of Adults with Active Psoriatic Arthritis (PsA)". Planegg....
[8] MorphoSys AG. (12/1/20). "Press Release: Thomas Biegi Joins MorphoSys as Head of Corporate Communications". Planegg....
[9] MorphoSys AG. (11/11/20). "Press Release: MorphoSys and Cherry Biolabs Announce Licensing of Hemibody Technology". Planegg & Würzburg....
[10] MorphoSys AG. (11/11/20). "Press Release: Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab". Monrovia, CA, Planegg & Wilmington, DE....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]